Kalina Tablets (Calidinogenase)

Adult dose

Administer 30-150 I.U. orally in 3 divided doses per day. The dose may be adjusted according to age and symptoms.

This medicine should not be used in patients with bleeding, such as immediately after a cerebral hemorrhage. Since this medicine contains lactose, it should not be administered to patients with genetic problems such as galactose intolerance, lactose deficiency, or glucose-galactose malabsorption. While taking this medicine, symptoms of hypersensitivity such as skin rash or itching may occur, so if these symptoms appear, use should be immediately discontinued. Tachycardia, which is a rapid heartbeat, may rarely occur, so caution is needed. Gastrointestinal symptoms may include stomach discomfort, nausea, vomiting, appetite loss, upper abdominal pain, diarrhea, or constipation. Additionally, rare symptoms may include fever, headache, heaviness in the head, drowsiness, and fatigue, so it is important to monitor the condition closely. Elderly patients may have reduced physical function, so special precautions such as dosage adjustments should be taken when using this medicine.

• Rash
• itching
• palpitations
• abdominal discomfort
• nausea
• vomiting
• loss of appetite
• upper abdominal pain
• diarrhea
• constipation

This medicine should be stored in a sealed container to prevent air or moisture from entering. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medicine.

Appearance

White circular enteric-coated film tablets

Package unit

30 tablets/bottle, 300 tablets/bottle